ATF4 and metabolic dysfunction-associated steatohepatitis: He and colleagues[37] reported that in non‐alcoholic steatohepatitis (NASH)‐induced Hepatocellular carcinoma (HCC) models, ATF4 deficiency increased susceptibility to ferroptosis via decreasing XCT expression, leading to accelerated development of HCC.